EUVIMEDScopri EUVIMED
Crossref

Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis

Qiaofang Liao, Jing Hu, Zhengyu Wu, Yanhui Jiang, Di Cheng, Huimou Chen iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70295 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Qiaofang Liao and 5 co-authors. Institution: Department of Oncology, The First Huizhou Affiliated Hospital of Guangdong Medical University, Huizhou, China. Major MEDLINE topics: Ferroptosis, Rhabdomyosarcoma, Proto-Oncogene Proteins c-akt, Phenanthrenes. Cited 1 times so far (Crossref); 46 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Rhabdomyosarcoma (RMS) is an aggressive pediatric soft tissue sarcoma with limited treatment options and poor prognosis. Dihydrotanshinone I (DT), a bioactive compound from Danshen, exhibits anti‐inflammatory and antitumor properties, but its effects on RMS remain unclear. To investigate the mode of cell death induced by DT, various inhibitors were employed. RNA sequencing and co‐immunoprecipitation assays were utilized to explore the mechanism of DT‐induced ferroptosis in RMS. Furthermore, the anti‐RMS efficacy of DT was evaluated through in vitro experimental models and nude mouse xenograft models. We found that DT induces the ubiquitination and degradation of HSP90AA1, thereby inhibiting the HSP90AA1/RACK1/AKT signaling axis and subsequently triggering ferroptosis in RMS. This process significantly suppresses the proliferation of RMS. These findings highlight the potential of DT as a therapeutic candidate for RMS and propose a ferroptosis‐targeting strategy that may improve treatment outcomes.

Subjects

MeSH terms (MEDLINE)

FerroptosisRhabdomyosarcomaProto-Oncogene Proteins c-aktPhenanthrenesHSP90 Heat-Shock ProteinsNeoplasm ProteinsAnimalsHumansCell Line, TumorMice, NudeMiceSignal TransductionXenograft Model Antitumor AssaysCell ProliferationFuransQuinones

Author keywords

Dihydrotanshinone IHSP90AA1RACK1ferroptosisrhabdomyosarcoma

Substances

dihydrotanshinone IProto-Oncogene Proteins c-aktPhenanthrenesHSP90 Heat-Shock ProteinsNeoplasm ProteinsFuransQuinones

Authors and institutions

  • Department of Oncology, The First Huizhou Affiliated Hospital of Guangdong Medical University, Huizhou, China.
  • Department of Oncology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Biomedical Innovation Center, the Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Radiotherapy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

ORCID profiles: Huimou Chen

Funding

  • National Natural Science Foundation of China

Cite

APA

Liao, Q., Hu, J., Wu, Z., Jiang, Y., Cheng, D., & Chen, H. (2026). Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis. Phytotherapy Research. https://doi.org/10.1002/ptr.70295

Vancouver

Liao Q, Hu J, Wu Z, Jiang Y, Cheng D, Chen H. Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis. Phytotherapy Research. 2026. doi:10.1002/ptr.70295

BibTeX
@article{Liao2026,
  author = {Liao, Qiaofang and Hu, Jing and Wu, Zhengyu and Jiang, Yanhui and Cheng, Di and Chen, Huimou},
  title = {Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70295}
}
Start for free →